Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Breakthroughs in AI Chips and Image Recognition Propel Market Growth and Business Enhancements

Published

on

breakthroughs-in-ai-chips-and-image-recognition-propel-market-growth-and-business-enhancements

USA News Group CommentaryIssued on behalf of Scope AI Corp.
VANCOUVER, BC, May 13, 2024 /PRNewswire/ — USA News Group – The race to improve artificial intelligence (AI) is accelerating at breakneck speed, with China recently unveiling a new photon-powered neural network microchip that can run on a thousandth as much energy as common electron-powered chips. According to analysts at DataHorizzon Research the AI Chip Market is set for explosive growth of over 40.6% CAGR through to 2032. As new chips improve, so too do the ways we use the chips to enhance businesses through AI-powered deep machine learning and neural networks. In one aspect that’s consistently improving is AI-powered image recognition, which Research and Markets projects to grow at a CAGR of 16.1% towards US$98.6 billion by 2029. This portion of the AI revolution is being rapidly implemented and improved by developers including Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF), Ambarella, Inc. (NASDAQ: AMBA), Ceva, Inc. (NASDAQ: CEVA), Himax Technologies, Inc. (NASDAQ: HIMX), and Autodesk, Inc. (NASDAQ: ADSK).

As the capabilities of deep machine learning expand across various industries, Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF) has rebranded and broadened its market reach. The company now targets sectors such as advertising, gaming, and neural networks with its proprietary technology, GEM (General Enterprise Machine Learning). This advanced platform enables businesses to develop their own object detection and visual information systems, leveraging the power of complete neural networks. By integrating object visual recognition, Scope AI is enhancing the ability of companies to personalize ad content, create immersive gaming experiences, and utilize neural networks for diverse applications.
Recently, Scope announced new updates to GEM, enhancing its functionality for advertising firms to tailor ad content more effectively, enabling the gaming industry to offer more personalized gameplay experiences, and utilizing the power of neural networks for advanced applications. These updates significantly boost the platform’s utility in object visual recognition, allowing businesses to gain deeper insights and deliver more precise solutions. By leveraging advanced object detection and visual information systems, advertisers can better analyze consumer behavior and optimize campaigns, while game developers can create richer, more engaging user experiences.
“We’re very pleased at how seamless we were able to streamline, enhance, and strengthen our platform with the latest performance and security upgrades made to our infrastructure,” said Sean Prescott, Founder and Non-Executive Chairman of Scope. “The next generation of our platform will set us apart in what kind of data and its sensitivity we can process and store. It’s a potential game-changer for the industry.”
GEM comes with an intuitive web-interface, a developer, detail user, entrepreneur or full-on enterprise could easily set up an object detection system to run advanced data inference, or build a completely new, never before seen neural network model in real-time.
Scope AI is optimistic that GEM’s latest updates can significantly advance the advertising and gaming industries by offering new insights and capabilities. For advertising, Scope explains that GEM’s visual recognition technology allows advertisers to create highly targeted and engaging ads. This approach not only maximizes return on ad spend but also drives customer engagement to new heights.
In the gaming sector, Scope believes GEM can significantly enhance user experiences by customizing gameplay and recommendations through neural network analysis of player behavior. GEM provides developers with crucial insights aimed at optimizing game design, increasing user retention, and maximizing revenue potential.
Looking to further empower AI developers, Ambarella, Inc. (NASDAQ: AMBA) announced its leading-edge CooperTM Developer Platform earlier this year. The platform was designed to offer seamless integration of software, hardware, state-of-the-art fine-tuned AI models, and services that provide universal support for Ambarella’s entire portfolio of AI systems-on-chip (SoCs).
“Developers creating products based on the latest AI technologies are faced with the daunting challenge of integrating multiple software tools while deploying on diverse hardware platforms,” said Fermi Wang, President and CEO of Ambarella. “Our new unified, robust and scalable Cooper Developer Platform allows designers to easily take full advantage of our SoCs’ industry-leading AI performance per watt, via intuitive and comprehensive tools that abstract the hardware and enable them to focus on product innovation across multiple markets and applications.”
Through April, Ambarella continued expanding its AI SoC portfolio, adding the CV75S family of 5nm chips, which the company claims offers the most cost- and power-efficient SoC option for running the latest AI-based image processing like vision language models (VLMs) and vision transformer networks in security, robotics, conferencing, and sports cameras.
Aiding in enhancing the connectivity required for smooth implementation of AI platforms is Ceva, Inc. (NASDAQ: CEVA), which recently launched a family of multi-protocol IP for edge AI and the Internet of Things (IoT) with a 22nm radio configuration. Named the Ceva-Waves Links, the new family of multi-protocol IP supports WiFi6, Bluetooth, and Ultra-Widband (UWB) features optimized co-existence schemes and are adapted to various radios and configurations.
Earlier this year, Ceva also expanded its AI ecosystem for its class-leading NeuPro-M NPU IP with the addition of two new partnerships targeting automotive and vision-based Edge AI applications.
“I would like to extend a warm welcome to Visionary.ai and ENOT.ai, who join the ecosystem of partners that support our Smart Edge customer base,” said Ran Snir, Vice President and General Manager of the Vision Business Unit at Ceva. “These partners are bringing new levels of innovation to solve complex challenges using AI, and illustrate the value proposition of our NeuPro-M NPU to enable scalable AI workloads on-device with highest power efficiency.”
Display driver and other semiconductors products suppliers Himax Technologies, Inc. (NASDAQ: HIMX) recently announced a collaboration with E Ink Holdings Inc., a pioneer and distinguished leader in ePaper technology, to introduce a revolutionary ultralow power battery-operated smart retail solution. In the realm of smart signage, Himax WiseEye AI is now revolutionizing e-signage by incorporating E Ink’s Kaleido display and offering a versatile suite of always-on sensing AI capabilities, including human presence and individual detection.
“The partnership between Himax and E Ink marks a significant evolution from our years of collaboration in the e-reader industry, now venturing into the domain of e-signage and ESL,” said Mark Chen, Vice President of Smart Sensing business at Himax. “Leveraging E Ink’s versatile ePaper technologies and extensive industry reach, combined with Himax’s robust AI and ultralow power expertise, our goal is to redefine the possibilities of next-generation e-signage and ESL products, envisioning enhanced precision, privacy, and versatility.”
Used by designers and architects, a platform built by 3D software company Autodesk, Inc. (NASDAQ: ADSK) recently demonstrated the capabilities of an ambitious generative AI project called Project Bernini, a text-to-3D tool. Project Bernini can create 3D images from a variety of input types including a text prompt, a single 2D image, multiple images and/or point clouds.
In late April, Autodesk also announced an interoperability agreement with Nemetschek Group to improve open collaboration and efficiencies for the architecture, engineering, construction and operations (AECO) and media and entertainment (M&E) industries. The duo will work together to enhance existing interoperability between each company’s industry cloud and desktop products and to improve the fluent exchange of information across solutions.
“Autodesk is firmly committed to building open, integrated, cloud-powered solutions for our customers that unlock data and connect project teams,” said Amy Bunszel, Executive Vice President, Architecture, Engineering and Construction Solutions at Autodesk. “Extending Autodesk’s cloud and desktop solutions with Nemetschek interoperability is a huge step towards optimizing our customers’ workflows and helping them generate better project outcomes.”
Article Source: https://usanewsgroup.com/2024/04/26/the-currency-of-tomorrow-why-investing-in-cutting-edge-ai-recognition-tech-could-mean-big-money/ 
CONTACT:
USA NEWS [email protected](604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Scope AI Corp. advertising and digital media from the company directly. There may be 3rd parties who may have shares Scope AI Corp., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Scope AI Corp. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Scope AI Corp. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

View original content:https://www.prnewswire.co.uk/news-releases/breakthroughs-in-ai-chips-and-image-recognition-propel-market-growth-and-business-enhancements-302143429.html

Continue Reading
Advertisement
Stake.com

Artificial Intelligence

Optellum showcases AI for precision lung cancer treatment at ASCO 2024

Published

on

optellum-showcases-ai-for-precision-lung-cancer-treatment-at-asco-2024

OXFORD, United Kingdom, May 30, 2024 /PRNewswire/ — Optellum, a global leader in AI-driven clinical decision support for early lung cancer diagnosis, has launched its multimodal therapy AI guidance platform for life science research. The novel AI software and scientific results, showing potential to optimize curative lung cancer treatment, will be showcased for the first time at the 2024 ASCO Annual Meeting in Chicago (31 May—4 June).

Lung cancer often shows no symptoms until it reaches an advanced stage, leaving patients with limited treatment options and less favorable outcomes. However, by continuous automated analysis of the 90 million CT scans US patients receive yearly, it may be possible to create an “early detection system”. Optellum Virtual Nodule Clinic, the first FDA-cleared decision support for early-stage lung cancer, integrates a Patient Discovery AI based on Natural Language Processing with a clinically validated Lung Cancer Prediction (LCP) score based on imaging AI/Radiomics. The combination assists clinicians in identifying at-risk patients across health systems and prioritizing them for follow-up interventions.
Early diagnosis offers patients curative treatment options. Unfortunately, some 30% to 60% of Stage I-II NSCLC patients will experience recurrence after surgery. Accurate prognosis of recurrence risk could enable thoracic oncology teams to optimize treatment early, for example, to tailor the extent of surgical resection and ensure neo-adjuvant and peri-operative treatments are offered to those at risk. To drug developers, it may enable risk-stratifying populations to increase treatment rates, expand indications to earlier stages, and predict treatment response.
Optellum will showcase their precision lung cancer care AI solutions at the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting. In the ASCO scientific program (Poster Session, 3rd June, 1:30 pm), Optellum’s clinical partners will present results of AI-guided recurrence prognosis in Stage I-III NSCLC from multi-modal pre-surgical data (Abstract #8066 1) showing significantly increased sensitivity for recurrence compared to staging. The Optellum AI solutions will also be demoed at the CancerLinQ booth (#14013) and ConcertAI booth (#12045).
Christine D. Berg, M.D., the co-principal investigator of the National Lung Screening Trial (NLST) at the National Cancer Institute, which paved the way for lung cancer screening implementation, commented: “The accurate determination of prognosis drives treatment decisions in oncology. Radiomic tools combined with demographics, as shown by Optellum, can be an effective non-invasive technology to optimize decision making early in the patient’s journey, which may help to improve outcomes.”
“Our multi-modal AI platform aims to become the ‘operating system’ that guides precision lung cancer care across the patient journey, from early identification to predicting response and monitoring,” said Václav Potěšil, PhD, Founder & Chief Business Officer at Optellum. “Neo-adjuvant therapies are real game changers. Together with our medtech and biopharma partners, we leverage the power of AI to help democratize access to life-saving early diagnosis and precision treatment for every patient who can benefit.”
Learn more here.
About OptellumOptellum is a commercial-stage lung health company providing artificial intelligence decision-support software that assists physicians in early diagnosis and optimal treatment for their patients. The company was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage when the probability of better health outcomes is highest. The Oxford-based medtech company has been the first to achieve FDA 510(k) clearance and reimbursability for US Medicare patients under CMS New Technology APC for the application of AI decision-support software in lung cancer diagnosis. It has since announced strategic partnerships with industry leaders, including GE Healthcare, Johnson & Johnson, and many other top biopharma and medtech companies, while Virtual Nodule Clinic has been implemented in healthcare systems across the USA and Europe. Optellum has headquarters at the Oxford Centre for Innovation in Oxford, UK, and a US office at the Texas Medical Center. For more information, visit optellum.com or follow us on LinkedIn.
Media Contact
Optellum Communications | [email protected]
1 Pre- and post-operative lung cancer recurrence prediction following curative surgery: A retrospective study using European radiomics and clinical data. Ann Valter, Tanel Kordemets, Aydan Gasimova, Noah Waterfield Price, Lutz Freitag, Anil Vachani, David Paul Carbone, Kersti Oselin, https://meetings.asco.org/abstracts-presentations/239181
Logo – https://mma.prnewswire.com/media/1596737/Optellum_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/optellum-showcases-ai-for-precision-lung-cancer-treatment-at-asco-2024-302159353.html

Continue Reading

Artificial Intelligence

Element Biosciences to Showcase Sequencing Innovations at the European Human Genetics Conference

Published

on

element-biosciences-to-showcase-sequencing-innovations-at-the-european-human-genetics-conference

Customers laud the positive impact of AVITI on advancing their scientific research
SAN DIEGO, May 30, 2024 /PRNewswire/ — Element Biosciences, Inc., developer of pioneering technologies to empower science, will showcase the rapidly growing use of its AVITI™ System sequencer across the European scientific community at the European Human Genetics Conference 2024 in Berlin, Germany, on June 1.  

During ESHG 2024, which runs from June 1-4, Element Biosciences’ Chief Technology Officer and Co-Founder Michael Previte will share the latest details on the AVITI24™, the first platform to combine state-of-the-art sequencing and multiomic cell analysis in one integrated biology tool.  The AVITI24 enables the simultaneous measurement of multiple analytes, including DNA, RNA, proteins, phosphorylated proteins, and morphology, in up to one million cells per flow cell.
“At ESHG, we’re excited to show the transformative power of AVITI and highlight how we’re advancing our mission to increase access to high-quality, affordable tools for complex biological research through AVITI24,” said Previte.
The AVITI System is expanding access to faster, more efficient and innovative sequencing for European scientific labs, with Element’s technologies now being used by researchers in most countries in Europe. With its AVITI24 open for preorders, Element also announced that existing customers are prebooking ahead of shipment, including the National Genomics Infrastructure (NGI) at SciLifeLab, a world-leading Swedish national center for large-scale research and one of the largest molecular biology research infrastructures in Europe.
“As part of the National Genomics Infrastructure, we’re committed to staying at the forefront of technology,” said Robert Månsson Welinder, Head of Strategic Relations at NGI. “Element’s AVITI24 will help us push this frontier and allow our scientific community to pursue new and exciting science.”
Leading European scientists emphasized the positive impact the AVITI has had on advancing their scientific research. Igor Fijalkowski, researcher at the Center for Medical Genetics at Ghent University in Belgium, noted the ease of adoption and flexibility of the platform saying “Over the last year or so we performed more than 100 runs of AVITI sequencing and overall, across multiple applications, the sequencing quality has been excellent. The transition was frictionless, so we are very happy with the way the sequencer has been performing.”
Several other researchers noted the cost-effectiveness, high quality, and flexibility of the AVITI platform. “Since the installation of our AVITI we have been blown away by its flexibility and quality outputs,” said Megan Hamilton, Genomics Facility Manager at the Babraham Institute in Cambridge, United Kingdom. Petri Auvinen, Research Director at the Institute of Biotechnology, University of Helsinki, Finland, said “AVITI seems to be the most efficient and most legitimate system to run a new chemistry for sequencing.”
Others called out the unique features of the AVITI not available on other platforms. “The cost-effectiveness of AVITI adds to its high sequencing quality of Q40-50, which makes it an important device in the future of cancer research,” said Romain Boidot, molecular biologist at the Georges-François Leclerc Center, France. Also in France, Charles Poncet, lab manager at INRAE, said “We chose AVITI for its combination of performance, price of the instrument and reagents, flexibility, and applications. We also had the chance to test AVITI with our wheat samples and the results were excellent, especially for an organism with such complex genetics.”
Two years after launching AVITI, the sequencer that provides the highest quality sequencing on a benchtop, Element has continued to innovate on its modular platform. It has introduced faster run times, expanded kit offerings, the Elembio Cloud software platform, and industry-leading affordability, while maintaining unprecedented accuracy.
About Element Biosciences, Inc.
Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multi-omics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries. To learn more about Element, please visit www.elementbiosciences.com and follow us on LinkedIn, X (Twitter), and Facebook.
Media Contact:Kristi HeimElement [email protected]
Logo – https://mma.prnewswire.com/media/1889504/Element_Biosciences_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/element-biosciences-to-showcase-sequencing-innovations-at-the-european-human-genetics-conference-302159209.html

Continue Reading

Artificial Intelligence

St. Pölten UAS: Networking Meeting of the Higher Education Area

Published

on

st.-polten-uas:-networking-meeting-of-the-higher-education-area

St. Pölten UAS Hosts 33rd EURASHE Annual Conference
Every year, the European Association of Institutions in Higher Education (EURASHE) brings together representatives of the higher education sector in order to discuss and design a common path in important matters for the present and future of education. This year’s meeting was held at the St. Pölten University of Applied Sciences. The focus of the event was on transnational collaborations between higher education institutions and on cooperation with the business world and society. More than 200 experts from all over Europe, Africa, Asia, and the Middle East took part.
ST. PÖLTEN, Austria, May 30, 2024 /PRNewswire/ — EURASHE, the European Association of Institutions in Higher Education, features approximately 600 universities, universities of applied sciences, university colleges, and similar institutions that conduct primarily professional higher education and applied research.

 
Important Voice in the European Higher Education Area”In order to come up with solutions to the diverse challenges of our times, it is necessary for us to integrate the knowledge and experiences of various fields and to further develop our creativity. In most cases, individual higher education institutions can generate only little impact unless they pool their forces. Therefore, international partnerships and university alliances are decisive for future-oriented development”, emphasises St. Pölten UAS CEO Hannes Raffaseder who is the current President of EURASHE. St. Pölten UAS is also the coordinator of the European University Alliance E³UDRES².
„Regarding higher education institutions it’s important that we have a diversity of voices in Europe and EURASHE is a very important voice for the universities of applied sciences. They bring in a different perspective. Typically they are very rooted in the local or regional context. They are close to the labour market and they are very innovative. So we need EURASHE to bring in their perspective and come up with new ideas on how we can make transnational cooperation work better at European level”, says Sophia Eriksson Watershoot, Director for Youth, Education and  Erasmus+ from the European Commission.
“I am happy to have our conference here in St. Pölten. The conference is different each year, and that is what makes EURASHE conferences so interesting. Here at this new campus, people get a feel of how fast changing this sector is. And we had a great diversity of people at the conference this year including guests from all around the world like North America, Asia, and the Middle East”, says John Edwards, Secretary General of EURASHE.
33rd EURASHE Annual Conferencehttps://www.eurashe.eu/events/annual-conference-2024https://www.eurashe.eu
Contact:Mark [email protected]+43 2742 313 228 ext. 269
Logo – https://mma.prnewswire.com/media/1735639/St_Polten_University_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/st-polten-uas-networking-meeting-of-the-higher-education-area-302159314.html

Continue Reading

Trending